BioSpace News Archive

MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation

MYND Life Sciences Inc. is pleased and extremely grateful to acknowledge the financial contribution from the Government of Canada towards an important component of its research and development into the positive effects of psilocybin on treating diseases of the brain.

November 30, 2021
·
3 min read
Bright Minds Biosciences Provides Scientific Update on its Novel 5-HT2A Psychedelic Program for the Treatment of Mental Diseases

Bright Minds Biosciences today provided a scientific update on the advancement of its novel 5-HT2A psychedelic program for the treatment of mental diseases.

November 30, 2021
·
6 min read
Bio NC

Heat Biologics Unveils RapidVax®, A Novel Cellular Vaccine Platform Targeting Known and Unknown Emerging Biological Threats

Heat Biologics, Inc. today unveiled its new RapidVax® cellular vaccine platform at the 2021 World Antiviral Congress.

November 30, 2021
·
6 min read
Pharm Country

Cognition Therapeutics to Host Virtual R&D Symposium December 7 on Dementia with Lewy Bodies and the Potential for Sigma-2 Modulation

Cognition Therapeutics, Inc. will hold a virtual R&D symposium on December 7, 2021, from 10:00am – 12:00pm ET.

November 30, 2021
·
4 min read
Policy

TG Therapeutics Provides Regulatory Update Company to host conference call today, Tuesday, November 30, 2021 at 8:30 AM ET

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the U.S. Food and Drug Administration (FDA) has notified the Company that it plans to host a meeting of the Oncologic Drugs Advisory Committee (ODAC) in connection with its review of the pending Biologics License Application (BLA).

November 30, 2021
·
16 min read
Medtronic receives Health Canada licence for GI Genius intelligent endoscopy module with artificial intelligence system for colonoscopy

Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE: MDT) — the global leader in medical technology — announced it has received a Health Canada licence for the GI Genius™ intelligent endoscopy module.

November 30, 2021
·
4 min read
Biotech Beach

GT Biopharma Abstract on Novel B7-H3 Immune Checkpoint Targeting Broad Spectrum Solid and Hematologic Malignancies Accepted for Presentation at ESMO IO Congress 2021

GT Biopharma, Inc. today announced that an abstract was accepted for presentation at the upcoming European Society for Medical Oncology (“ESMO”) Immuno-Oncology (“IO”) Congress 2021 to be held December 8-11, 2021 in Geneva Switzerland.

November 30, 2021
·
5 min read
Pharm Country

Notice of Allowance Issued for Method of Treating Cytokine Storm Using Melanocortin-Specific Peptide

Palatin Technologies, Inc. today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for application No.: 16/927,347.

November 30, 2021
·
3 min read
Business

Inflammatix Appoints Dr. Kian Beyzavi as New Board Member

Inflammatix announced today the appointment of Kian Beyzavi, PhD, as an independent member of the company’s board of directors.

November 30, 2021
·
2 min read
Drug Development

Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress

Cybin Inc. today announced that the U.S. Food and Drug Administration (“FDA”) has authorized an investigator-initiated randomized, placebo-controlled Phase 2 clinical trial evaluating psychedelic-assisted psychotherapy with psilocybin for frontline clinicians experiencing COVID-related distress.

November 30, 2021
·
9 min read